Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
InMode
INMD
InMode
Aging Demographics And FDA Hurdles Will Shrink Demand
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
12 May 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$14.00
5.8% overvalued
intrinsic discount
20 Aug
US$14.81
Loading
1Y
-8.9%
7D
3.2%
Author's Valuation
US$14.0
5.8% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$14.0
5.8% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
499m
2016
2018
2020
2022
2024
2025
2026
2028
Revenue US$383.8m
Earnings US$83.3m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.11%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
9.33%
Calculation
US$83.34m
Earnings '28
x
10.98x
PE Ratio '28
=
US$915.27m
Market Cap '28
US$915.27m
Market Cap '28
/
50.88m
No. shares '28
=
US$17.99
Share Price '28
US$17.99
Share Price '28
Discounted to 2025 @ 9.35% p.a.
=
US$13.76
Fair Value '25
